jocelynhudson

39 POSTS 0 COMMENTS

Renal denervation still holds strong potential as a therapy for hypertension

Although renal denervation may not hit the heights originally envisaged for it in the management of hypertension, and areas of uncertainty remain, Partha Sardar...

Low-dose polypill could be used for primary prevention of cardiovascular events

A polypill that combines four cardiovascular drugs has been shown to reduce the risk of major cardiovascular events in the general population when taken...

FARXIGA meets primary endpoint in Phase III DAPA-HF trial

AstraZeneca has announced positive results from the Phase III DAPA-HF trial which showed that FARXIGA (dapagliflozin) met the primary composite endpoint with a statistically-significant...

CeloNova appoints new president and CEO

CeloNova has announced the appointment of Carl J St. Bernard as president and chief executive officer (CEO). According to CeloNova, St. Bernard joins the company...

FDA approves new device to improve symptoms in patients with advanced...

The US Food and Drug Administration has approved the Barostim Neo system for the improvement of symptoms in patients with advanced heart failure who...

Novel wireless pressure monitoring system will have an “enormous impact” on...

Horst Sievert (Frankfurt, Germany) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about the VECTOR-HF trial which evaluated the safety, usability and performance of a novel wireless pressure...

Announcing the TCT 2019 late-breaking trials and science

The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-breaking science presentations that will be reported at the Transcatheter Cardiovascular...

Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

wirion
Cardiovascular Systems recently announced that it has acquired the Wirion embolic protection system and related assets from Gardia Medical. The device, which received CE Mark...

Transcatheter repair of tricuspid valves appears safe and effective when surgery...

Data from two new studies suggest that transcatheter tricuspid valve repair (TTVr) is a safe and effective treatment option for patients with symptomatic or...

Hormone therapy linked to heart fat and hard arteries

Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health (Pittsburgh,...

SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device...

B Braun Interventional Systems has announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for the SeQuent Please ReX...

EuroPCR 2019: Allegra Transcatheter Heart Valve shows “very good haemodynamic outcomes”

Ulrich Schäfer (Hamburg, Germany) speaks to Cardiovascular News at EuroPCR (21–24 May, Paris) about the VIVALL study which looked at the safety and efficacy...

TRILUMINATE trial shows “extremely favourable” results in patients with tricuspid regurgitation

Speaking to Cardiovascular News at EuroPCR 2019 (21–24 May, Paris, France), Georg Nickenig (Bonn, Germany), discusses the results of the TRILUMINATE trial which looked...

ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative

pascal repair
This content is only for readers outside of the US as it discusses a device that is not FDA approved. On February 12, 2019, Edwards...

Philips launches IntraSight interventional applications platform

Royal Philips recently announced the launch of the new IntraSight interventional applications platform. According to a press release, the secure, application-based platform offers a...

Boston Scientific initiates trial comparing left atrial appendage closure to direct...

According to a press release, Boston Scientific has initiated the OPTION trial to compare safety and effectiveness of the next-generation Watchman FLX left atrial...

Medtronic launches Telescope guide extension catheter

Medtronic recently announced the global launch of the Telescope guide extension catheter, a newly designed catheter used to provide additional backup support and access...

CE mark for Watchman FLX left atrial appendage closure device

Boston Scientific announced it has received CE mark and initiated a limited market release of the next generation Watchman FLX left atrial appendage closure...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 January 2019. Rothman is a pioneer in interventional cardiology, as...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 January 2019. Rothman is a pioneer in interventional cardiology, as...

Philips launces Azurion with FlexArm to aid image-guided procedures

Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-guided procedures. During increasingly complex interventions, clinicians need to quickly and easily...

Positive results for LivaNova’s Perceval sutureless valve

Three newly published studies highlight the safety, efficacy, and economic advantage of the Pervecal sutureless aortic valve (LivaNova). The results from the Perceval Aortic...

Abbott to acquire Cephea Valve Technologies

It was recently announced that Abbott has exercised its option to purchase Cephea Valve Technologies. Financial terms were not disclosed. Abbott provided capital and...

New JACC publication reinforces valve of a coronary CTA + HeartFlow...

HeartFlow has announced the publication of the PACIFIC substudy showing that their FFRct Analysis demonstrates the highest diagnostic performance for detecting coronary artery disease...

JenaValve Technology appoints John T Kilcoyne as chief executive officer

Medical device executive John T Kilcoyne has been appointed as chief executive officer of JenaValve Technology, effective immediately. In addition, he will serve as...

Shockwave initiates US pivotal study for coronary intravascular lithotripsy

  Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study—DISRUPT CAD III—for the use of Intravascular Lithotripsy (IVL)...

First patients in the Middle East treated with Diamondback 360 Coronary...

  The first patients in the United Arab Emirates (UAE) have been treated with the Diamondback 360 Coronary Orbital Atherectomy System (OAS; Cardiovascular Systems). The first UAE...

Sleeping less than six hours a night may increase cardiovascular risk

People who sleep less than six hours a night may be at increased risk of cardiovascular disease compared with those who sleep between seven...

FDA approves world’s first device for treatment of premature babies and...

The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the world's first medical device that can be implanted in...

Boston Scientific, Edwards Lifesciences agree to global litigation settlement

Boston Scientific and Edwards Lifesciences today announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in...

Does your insurance card matter when you have a heart attack?

Medicaid reimbursement to healthcare facilities on ST-elevation myocardial management—or STEMI, a serious form of a heart attack—is often lower when compared with the reimbursement...

SCCT releases new guideline for use of computed tomography in TAVR...

The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed tomography imaging to improve outcomes for patients undergoing...

Patient recruitment reaches half-way point for global DAPT study

December marked a significant milestone for a major study into the use of short duration dual anti-platelet therapy (DAPT) in high bleeding risk patients...

First United States treatment with J-Valve TAVI device

The first US patient has been successfully treated with JC Medical's transfemoral transcatheter aortic valve implantation (TAVI) device, the J-Valve TF system. The patient...

Sapien 3 Ultra receives FDA approval

It has been announced that the Sapien 3 Ultra system (Edwards Lifesciences) has received US FDA approval for transcatheter aortic valve implantation (TAVI) in...

Internationally renowned cardiac surgeon joins University of Miami Health System

Joseph Lamelas, an internationally recognised expert cardiac surgeon who helped pioneer minimally invasive approaches to cardiac surgery, has joined the University of Miami Health...

FFRangio system receives US FDA clearance

US FDA 510(k) clearance has been granted for the FFRangio System (CathWorks). The FFRangio system demonstrated accuracy versus the invasive FFR wire in a...

Boston Scientific exercises option to acquire Millipede

Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon its recent successful completion of a first-in-human clinical study. The...

First patients treated in United States with OrbusNeich Teleport Microcatheter

The first patients in the United States have been treated using the OrbusNeich Teleport Microcatheter (Teleport; Cardiovascular Systems), which recently received US Food and...